Prevention of Infection in Indian Neonates - Phase I Observational Study

NCT00518609 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1326

Last updated 2014-07-31

No results posted yet for this study

Summary

India, with one of the world's largest populations, continues to struggle with extremely high infant and neonatal mortality rates. Neonatal infection (sepsis) now accounts for 50 percent of deaths among community-born (and 20 percent of mortality among hospital-born) infants. This study is the first phase of a multi-phase project investigating interventions to prevent neonatal infection in India.

Conditions

Sponsors & Collaborators

  • Global Network for Women's and Children's Health Research

    collaborator OTHER
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Fogarty International Center of the National Institute of Health

    collaborator NIH
  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • National Institute of Dental and Craniofacial Research (NIDCR)

    collaborator NIH
  • National Cancer Institute (NCI)

    collaborator NIH
  • RTI International

    collaborator OTHER
  • All India Institute of Medical Sciences

    collaborator OTHER
  • TN Medical College, Mumbai

    collaborator OTHER
  • Department of Health and Family Welfare, Orissa

    collaborator OTHER
  • SCB Medical College, Cuttack

    collaborator OTHER
  • Capital Hospital, Bhubaneswar

    collaborator OTHER
  • Ispat General Hospital, Rourkela

    collaborator OTHER
  • Kalinga Hospital, Bhubaneswar

    collaborator OTHER
  • University of Maryland

    collaborator OTHER
  • NICHD Global Network for Women's and Children's Health

    lead NETWORK

Principal Investigators

  • Pinaki Panigrahi, M.D. · University of Maryland, Baltimore

Eligibility

Max Age
60 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-07-31
Completion
2006-07-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00518609 on ClinicalTrials.gov